Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
9 resultater
Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD
The present disclosure relates to treatment and management of Hypercortisolemia, Headache disorders and Neuropathic pain using a composition comprising asiaticoside and madecasosside optionally along with at least one excipient.
BACKGROUND AND PRIOR ART
Serotonin is a
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD
The present invention is directed to certain isoxazolone compounds that inhibit the release of inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells. The compounds of the invention, therefore, are useful in treating diseases involving unwanted
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD
The present invention is directed to certain isoxazolone compounds that inhibit the release of inflammatory cytokines such as interleukin-1 (1L-1) and tumor necrosis factor (TNF) from cells. The compounds of the invention, therefore, are useful in treating diseases involving unwanted
NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
1. Field of the invention
The invention relates to a pharmaceutical and a method for treating Chronic Fatigue Syndrome and alleviating the symptoms thereof. More particularly, the invention relates to the use of reduced forms of nicotinamide-adenine-dinucleotide (NADH) or
Use of Epinastine for the treatment of pain
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
This application is a 371 of PCT/EP96/04957, filed Nov. 13, 1996.
The present invention relates to a new use of epinastine for the treatment and prophylaxis of pain, especially chronic or inflammation-induced pain and in particular migraine.
Epinastine
Compositions and methods for the treatment of moderate to severe pain
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
This disclosure generally relates to compounds and compositions for the treatment of moderate to severe pain. More particularly, this invention relates to treating subjects with a pharmaceutically acceptable dose of compounds, crystals, enantiomers, stereoisomers, esters,
Compositions and methods for the treatment of moderate to severe pain
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
PRIORITY
This application is a national phase filing of the Patent Cooperation Treaty (PCT) application # PCT/IB2013/055146 titled "COMPOSITIONS AND METHODS FOR THE TREATMENT OF MODERATE TO SEVERE PAIN" filed on Jun. 23, 2013 Published with WIPO Publication # WO/2014/006529, which further claims
Cannabinoid receptor modulators
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage Application under 35 U.S.C. .sctn.371 of International Application No. PCT/US2010/002360, filed Aug. 27, 2010, which claims priority under 35 U.S.C. .sctn.119(e) to U.S. Provisional Application Nos. 61/275,506, filed Aug.
Cannabinoid receptor modulators
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to certain compounds of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB.sub.2 receptor. The present invention further relates to certain compounds of Formula Ia and pharmaceutical compositions
Den mest komplette database med medicinske urter understøttet af videnskab
- Arbejder på 55 sprog
- Urtekurer, der understøttes af videnskab
- Urtegenkendelse ved billede
- Interaktivt GPS-kort - tag urter på stedet (kommer snart)
- Læs videnskabelige publikationer relateret til din søgning
- Søg medicinske urter efter deres virkninger
- Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter
Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning
